FDMT logo

FDMT Long Term Liabilities

Annual Total Long Term Liabilities

$13.11 M
-$1.67 M-11.28%

December 31, 2023


Summary


Performance

FDMT Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFDMTbalance sheetmetrics:

Quarterly Long Term Liabilities

$21.61 M
+$9.24 M+74.68%

September 30, 2024


Summary


Performance

FDMT Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFDMTbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

FDMT Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-11.3%+59.9%
3 y3 years-13.7%+59.9%
5 y5 years-88.8%+59.9%

FDMT Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-27.3%at lowat high+74.7%
5 y5-year-88.9%at low-81.7%+389.3%
alltimeall time-88.9%at low-81.7%+389.3%

4D Molecular Therapeutics Long Term Liabilities History

DateAnnualQuarterly
Sep 2024
-
$21.61 M(+74.7%)
Jun 2024
-
$12.37 M(-4.2%)
Mar 2024
-
$12.92 M(-1.5%)
Dec 2023
$13.11 M(-11.3%)
$13.11 M(-3.0%)
Sep 2023
-
$13.52 M(-0.7%)
Jun 2023
-
$13.61 M(-3.7%)
Mar 2023
-
$14.14 M(-4.3%)
Dec 2022
$14.78 M
$14.78 M(-2.5%)
Sep 2022
-
$15.16 M(-5.8%)
Jun 2022
-
$16.09 M(-4.1%)
DateAnnualQuarterly
Mar 2022
-
$16.78 M(-7.0%)
Dec 2021
$18.04 M(+18.7%)
$18.04 M(+253.0%)
Sep 2021
-
$5.11 M(+15.7%)
Jun 2021
-
$4.42 M(-67.9%)
Mar 2021
-
$13.77 M(-9.4%)
Dec 2020
$15.20 M(-87.1%)
$15.20 M(+10.5%)
Sep 2020
-
$13.76 M(-88.4%)
Dec 2019
$118.25 M(+1.5%)
$118.25 M(+3.5%)
Jun 2019
-
$114.20 M(-2.0%)
Dec 2018
$116.50 M(+184.1%)
$116.50 M
Dec 2017
$41.00 M
-

FAQ

  • What is 4D Molecular Therapeutics annual total long term liabilities?
  • What is the all time high annual total long term liabilities for 4D Molecular Therapeutics?
  • What is 4D Molecular Therapeutics annual total long term liabilities year-on-year change?
  • What is 4D Molecular Therapeutics quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for 4D Molecular Therapeutics?
  • What is 4D Molecular Therapeutics quarterly long term liabilities year-on-year change?

What is 4D Molecular Therapeutics annual total long term liabilities?

The current annual total long term liabilities of FDMT is $13.11 M

What is the all time high annual total long term liabilities for 4D Molecular Therapeutics?

4D Molecular Therapeutics all-time high annual total long term liabilities is $118.25 M

What is 4D Molecular Therapeutics annual total long term liabilities year-on-year change?

Over the past year, FDMT annual total long term liabilities has changed by -$1.67 M (-11.28%)

What is 4D Molecular Therapeutics quarterly total long term liabilities?

The current quarterly long term liabilities of FDMT is $21.61 M

What is the all time high quarterly long term liabilities for 4D Molecular Therapeutics?

4D Molecular Therapeutics all-time high quarterly total long term liabilities is $118.25 M

What is 4D Molecular Therapeutics quarterly long term liabilities year-on-year change?

Over the past year, FDMT quarterly total long term liabilities has changed by +$8.10 M (+59.92%)